ATE365731T1 - 4-amino-5-cyanopyrimidinderivate - Google Patents
4-amino-5-cyanopyrimidinderivateInfo
- Publication number
- ATE365731T1 ATE365731T1 AT05738867T AT05738867T ATE365731T1 AT E365731 T1 ATE365731 T1 AT E365731T1 AT 05738867 T AT05738867 T AT 05738867T AT 05738867 T AT05738867 T AT 05738867T AT E365731 T1 ATE365731 T1 AT E365731T1
- Authority
- AT
- Austria
- Prior art keywords
- cyanopyrimidene
- derivatives
- amino
- cyanopyrimidene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004135999 | 2004-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365731T1 true ATE365731T1 (de) | 2007-07-15 |
Family
ID=35242255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05738867T ATE365731T1 (de) | 2004-04-30 | 2005-04-28 | 4-amino-5-cyanopyrimidinderivate |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7834002B2 (de) |
| EP (1) | EP1740574B1 (de) |
| KR (1) | KR101279689B1 (de) |
| CN (1) | CN1976922B (de) |
| AR (1) | AR049085A1 (de) |
| AT (1) | ATE365731T1 (de) |
| AU (1) | AU2005238391B2 (de) |
| BR (1) | BRPI0509454A (de) |
| CA (1) | CA2563846C (de) |
| CY (1) | CY1106764T1 (de) |
| DE (1) | DE602005001508T2 (de) |
| DK (1) | DK1740574T3 (de) |
| ES (1) | ES2288744T3 (de) |
| HK (1) | HK1100775A1 (de) |
| MX (1) | MXPA06012639A (de) |
| MY (1) | MY138996A (de) |
| PL (1) | PL1740574T3 (de) |
| PT (1) | PT1740574E (de) |
| RU (1) | RU2386628C2 (de) |
| SI (1) | SI1740574T1 (de) |
| TW (1) | TWI346109B (de) |
| WO (1) | WO2005105778A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2089016A4 (de) * | 2006-10-03 | 2014-10-08 | Univ Pennsylvania | Verfahren zur behandlung von makuladegeneration |
| TWI452044B (zh) | 2007-06-15 | 2014-09-11 | Mitsubishi Tanabe Pharma Corp | 嗎啉衍生物 |
| EP2265118A2 (de) * | 2008-03-19 | 2010-12-29 | Bayer CropScience AG | Hydroximoyl-tetrazol-derivate als fungizide |
| AR075196A1 (es) | 2009-02-03 | 2011-03-16 | Otsuka Pharma Co Ltd | Un derivado de cianopirimidina para el tratamiento de una enfermedad ocular |
| HUE035750T2 (en) * | 2012-01-26 | 2018-05-28 | Inotek Pharmaceuticals Corp | Polymorph (2R, 3S, 4R, 5R) -5- (6- (Cyclopentylamino) -9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate anhydrides and processes for their preparation |
| JP6095580B2 (ja) * | 2012-02-13 | 2017-03-15 | 武田薬品工業株式会社 | 芳香環化合物 |
| US11629139B2 (en) | 2017-09-08 | 2023-04-18 | President And Fellows Of Harvard College | Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use |
| WO2019072143A1 (zh) * | 2017-10-11 | 2019-04-18 | 上海迪诺医药科技有限公司 | 4-氨基吡啶衍生物、其药物组合物、制备方法及应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6299395A (ja) | 1985-10-25 | 1987-05-08 | Yamasa Shoyu Co Ltd | ２−アルキニルアデノシンおよび抗高血圧剤 |
| US4968697A (en) | 1987-02-04 | 1990-11-06 | Ciba-Geigy Corporation | 2-substituted adenosine 5'-carboxamides as antihypertensive agents |
| DE68916036T2 (de) | 1988-11-15 | 1994-09-29 | Yamasa Shoyu Kk | Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen. |
| IT1254915B (it) | 1992-04-24 | 1995-10-11 | Gloria Cristalli | Derivati di adenosina ad attivita' a2 agonista |
| US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
| US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
| US5877180A (en) | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
| TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
| CO4990969A1 (es) | 1998-02-14 | 2000-12-26 | Glaxo Group Ltd | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol |
| GB9813535D0 (en) | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
| GB9813540D0 (en) | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
| GB9813565D0 (en) | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
| DE69910213T2 (de) | 1998-06-23 | 2004-07-01 | Glaxo Group Ltd., Greenford | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivate |
| JP2002173427A (ja) | 1998-09-01 | 2002-06-21 | Yamasa Shoyu Co Ltd | 眼疾患治療用医薬組成物 |
| EP1121372B1 (de) | 1998-10-16 | 2006-06-28 | Pfizer Limited | Adenine-derivate |
| US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
| GB9913932D0 (en) | 1999-06-15 | 1999-08-18 | Pfizer Ltd | Purine derivatives |
| US6180615B1 (en) | 1999-06-22 | 2001-01-30 | Cv Therapeutics, Inc. | Propargyl phenyl ether A2A receptor agonists |
| AU768530B2 (en) | 1999-06-22 | 2003-12-18 | Gilead Palo Alto, Inc. | Thiophene A2A receptor agonists |
| US6214807B1 (en) | 1999-06-22 | 2001-04-10 | Cv Therapeutics, Inc. | C-pyrazole 2A A receptor agonists |
| US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
| DE19947154A1 (de) | 1999-10-01 | 2001-10-04 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| GB9924361D0 (en) | 1999-10-14 | 1999-12-15 | Pfizer Ltd | Purine derivatives |
| DE10110438A1 (de) | 2001-03-05 | 2002-09-19 | Bayer Ag | Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| DE10110747A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
| DE10110754A1 (de) | 2001-03-07 | 2002-09-19 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| DE10115922A1 (de) | 2001-03-30 | 2002-10-10 | Bayer Ag | Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| DE10134481A1 (de) | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
| JP2003055395A (ja) | 2001-08-10 | 2003-02-26 | Toa Eiyo Ltd | アデノシン誘導体 |
| DE10238113A1 (de) | 2001-12-11 | 2003-06-18 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
| JP2003206230A (ja) | 2002-01-10 | 2003-07-22 | Yamanouchi Pharmaceut Co Ltd | シアノヘテロ環誘導体又はその塩 |
-
2005
- 2005-04-26 TW TW094113204A patent/TWI346109B/zh not_active IP Right Cessation
- 2005-04-27 MY MYPI20051851A patent/MY138996A/en unknown
- 2005-04-28 ES ES05738867T patent/ES2288744T3/es active Active
- 2005-04-28 BR BRPI0509454-2A patent/BRPI0509454A/pt not_active Application Discontinuation
- 2005-04-28 PT PT05738867T patent/PT1740574E/pt unknown
- 2005-04-28 DK DK05738867T patent/DK1740574T3/da active
- 2005-04-28 CN CN2005800212589A patent/CN1976922B/zh not_active Expired - Fee Related
- 2005-04-28 US US11/579,067 patent/US7834002B2/en not_active Expired - Fee Related
- 2005-04-28 EP EP05738867A patent/EP1740574B1/de active Active
- 2005-04-28 SI SI200530047T patent/SI1740574T1/sl unknown
- 2005-04-28 AU AU2005238391A patent/AU2005238391B2/en not_active Ceased
- 2005-04-28 AT AT05738867T patent/ATE365731T1/de active
- 2005-04-28 WO PCT/JP2005/008568 patent/WO2005105778A2/en active Application Filing
- 2005-04-28 RU RU2006142323/04A patent/RU2386628C2/ru not_active IP Right Cessation
- 2005-04-28 CA CA2563846A patent/CA2563846C/en not_active Expired - Fee Related
- 2005-04-28 PL PL05738867T patent/PL1740574T3/pl unknown
- 2005-04-28 KR KR1020067025266A patent/KR101279689B1/ko active IP Right Grant
- 2005-04-28 MX MXPA06012639A patent/MXPA06012639A/es active IP Right Grant
- 2005-04-28 DE DE602005001508T patent/DE602005001508T2/de active Active
- 2005-04-29 AR ARP050101725A patent/AR049085A1/es not_active Application Discontinuation
-
2007
- 2007-06-04 HK HK07105890A patent/HK1100775A1/xx not_active IP Right Cessation
- 2007-07-25 CY CY20071100998T patent/CY1106764T1/el unknown
-
2010
- 2010-09-22 US US12/923,451 patent/US7989446B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR101279689B1 (ko) | 2013-06-27 |
| RU2006142323A (ru) | 2008-06-10 |
| TW200540161A (en) | 2005-12-16 |
| CA2563846A1 (en) | 2005-11-10 |
| AR049085A1 (es) | 2006-06-28 |
| DK1740574T3 (da) | 2007-10-15 |
| SI1740574T1 (sl) | 2007-12-31 |
| WO2005105778A3 (en) | 2006-10-26 |
| DE602005001508T2 (de) | 2008-02-28 |
| US20080182854A1 (en) | 2008-07-31 |
| US7834002B2 (en) | 2010-11-16 |
| CA2563846C (en) | 2011-12-20 |
| US7989446B2 (en) | 2011-08-02 |
| TWI346109B (en) | 2011-08-01 |
| HK1100775A1 (en) | 2007-09-28 |
| DE602005001508D1 (de) | 2007-08-09 |
| CY1106764T1 (el) | 2012-05-23 |
| CN1976922B (zh) | 2012-09-05 |
| AU2005238391A1 (en) | 2005-11-10 |
| KR20070008715A (ko) | 2007-01-17 |
| AU2005238391B2 (en) | 2010-12-16 |
| BRPI0509454A (pt) | 2007-09-04 |
| EP1740574A2 (de) | 2007-01-10 |
| EP1740574B1 (de) | 2007-06-27 |
| PT1740574E (pt) | 2007-09-06 |
| MXPA06012639A (es) | 2006-12-15 |
| PL1740574T3 (pl) | 2007-11-30 |
| RU2386628C2 (ru) | 2010-04-20 |
| ES2288744T3 (es) | 2008-01-16 |
| CN1976922A (zh) | 2007-06-06 |
| US20110009620A1 (en) | 2011-01-13 |
| WO2005105778A2 (en) | 2005-11-10 |
| MY138996A (en) | 2009-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2019034I2 (el) | 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
| DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
| ATE540935T1 (de) | Chinazolinderivate | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
| ATE520680T1 (de) | Hiv-hemmende 5-heterocyclylpyrimidine | |
| ATE392425T1 (de) | Thiazolyl-dihydro-indazole | |
| ATE459633T1 (de) | Makrolide | |
| DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
| ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
| DE112005000809A5 (de) | Wankstabilisierungseinrichtung | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
| DK1971588T3 (da) | Tiglien-3-onderivater | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| DK1740574T3 (da) | 4-amino-5-cyanopyrimidinderivater | |
| AT500198B8 (de) | Ladewagen | |
| ATE389633T1 (de) | Omega-phenyloctanamide | |
| DE112005000794T5 (de) | Urethanspritzpistolenanordnung | |
| ATE541837T1 (de) | Oxaphenanthren-derivate | |
| AT500249A3 (de) | Scheibenegge | |
| DE502004001961D1 (de) | Barikadenbrecher | |
| DE602006019209D1 (de) | Fluoroalkylpyrrolidin-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1740574 Country of ref document: EP |